COVID-19 Impact on Global Rosuvastatin, Market Insights and Forecast to 2026

Publisher Name :
Date: 29-Jun-2020
No. of pages: 154
Inquire Before Buying

Rosuvastatin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rosuvastatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Rosuvastatin market is segmented into

- Purity 98.0%

- Purity 99.0%

- Other

Segment by Application, the Rosuvastatin market is segmented into

- Tablet

- Capsule

- Others

Regional and Country-level Analysis

The Rosuvastatin market is analysed and market size information is provided by regions (countries).

The key regions covered in the Rosuvastatin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Rosuvastatin Market Share Analysis

Rosuvastatin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Rosuvastatin business, the date to enter into the Rosuvastatin market, Rosuvastatin product introduction, recent developments, etc.

The major vendors covered:

- AstraZeneca

- Teva Pharmaceutical Industries

- MSN Laboratories

- Cadila Pharmaceuticals

- LGM Pharma

- Bal Pharma

- Changzhou Pharmaceutical Factory

- Jingxin Pharm

- Zhejiang Hisun Pharmaceutical

- HEC Pharm

- Lunan Pharmaceutical

- Nanjing Frochem Tech

- Lianyungang Runzhong Pharmaceutical

- Shandong Bechem Chemicals

- CTX Life Sciences

COVID-19 Impact on Global Rosuvastatin, Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Rosuvastatin Product Introduction
1.2 Market Segments
1.3 Key Rosuvastatin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Rosuvastatin Market Size Growth Rate by Type
1.4.2 Purity 98.0%
1.4.3 Purity 99.0%
1.4.4 Other
1.5 Market by Application
1.5.1 Global Rosuvastatin Market Size Growth Rate by Application
1.5.2 Tablet
1.5.3 Capsule
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Rosuvastatin Industry Impact
1.6.1 How the Covid-19 is Affecting the Rosuvastatin Industry
1.6.1.1 Rosuvastatin Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Rosuvastatin Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Rosuvastatin Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Rosuvastatin Market Size Estimates and Forecasts
2.1.1 Global Rosuvastatin Revenue 2015-2026
2.1.2 Global Rosuvastatin Sales 2015-2026
2.2 Rosuvastatin Market Size by Region: 2020 Versus 2026
2.2.1 Global Rosuvastatin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Rosuvastatin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Rosuvastatin Competitor Landscape by Players
3.1 Rosuvastatin Sales by Manufacturers
3.1.1 Rosuvastatin Sales by Manufacturers (2015-2020)
3.1.2 Rosuvastatin Sales Market Share by Manufacturers (2015-2020)
3.2 Rosuvastatin Revenue by Manufacturers
3.2.1 Rosuvastatin Revenue by Manufacturers (2015-2020)
3.2.2 Rosuvastatin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Rosuvastatin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Rosuvastatin Revenue in 2019
3.2.5 Global Rosuvastatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Rosuvastatin Price by Manufacturers
3.4 Rosuvastatin Manufacturing Base Distribution, Product Types
3.4.1 Rosuvastatin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Rosuvastatin Product Type
3.4.3 Date of International Manufacturers Enter into Rosuvastatin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Rosuvastatin Market Size by Type (2015-2020)
4.1.1 Global Rosuvastatin Sales by Type (2015-2020)
4.1.2 Global Rosuvastatin Revenue by Type (2015-2020)
4.1.3 Rosuvastatin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Rosuvastatin Market Size Forecast by Type (2021-2026)
4.2.1 Global Rosuvastatin Sales Forecast by Type (2021-2026)
4.2.2 Global Rosuvastatin Revenue Forecast by Type (2021-2026)
4.2.3 Rosuvastatin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Rosuvastatin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Rosuvastatin Market Size by Application (2015-2020)
5.1.1 Global Rosuvastatin Sales by Application (2015-2020)
5.1.2 Global Rosuvastatin Revenue by Application (2015-2020)
5.1.3 Rosuvastatin Price by Application (2015-2020)
5.2 Rosuvastatin Market Size Forecast by Application (2021-2026)
5.2.1 Global Rosuvastatin Sales Forecast by Application (2021-2026)
5.2.2 Global Rosuvastatin Revenue Forecast by Application (2021-2026)
5.2.3 Global Rosuvastatin Price Forecast by Application (2021-2026)
6 North America
6.1 North America Rosuvastatin by Country
6.1.1 North America Rosuvastatin Sales by Country
6.1.2 North America Rosuvastatin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Rosuvastatin Market Facts & Figures by Type
6.3 North America Rosuvastatin Market Facts & Figures by Application
7 Europe
7.1 Europe Rosuvastatin by Country
7.1.1 Europe Rosuvastatin Sales by Country
7.1.2 Europe Rosuvastatin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Rosuvastatin Market Facts & Figures by Type
7.3 Europe Rosuvastatin Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Rosuvastatin by Region
8.1.1 Asia Pacific Rosuvastatin Sales by Region
8.1.2 Asia Pacific Rosuvastatin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Rosuvastatin Market Facts & Figures by Type
8.3 Asia Pacific Rosuvastatin Market Facts & Figures by Application
9 Latin America
9.1 Latin America Rosuvastatin by Country
9.1.1 Latin America Rosuvastatin Sales by Country
9.1.2 Latin America Rosuvastatin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Rosuvastatin Market Facts & Figures by Type
9.3 Central & South America Rosuvastatin Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Rosuvastatin by Country
10.1.1 Middle East and Africa Rosuvastatin Sales by Country
10.1.2 Middle East and Africa Rosuvastatin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Rosuvastatin Market Facts & Figures by Type
10.3 Middle East and Africa Rosuvastatin Market Facts & Figures by Application
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description, Business Overview and Total Revenue
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Rosuvastatin Products Offered
11.1.5 AstraZeneca Recent Development
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Corporation Information
11.2.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue
11.2.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Teva Pharmaceutical Industries Rosuvastatin Products Offered
11.2.5 Teva Pharmaceutical Industries Recent Development
11.3 MSN Laboratories
11.3.1 MSN Laboratories Corporation Information
11.3.2 MSN Laboratories Description, Business Overview and Total Revenue
11.3.3 MSN Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.3.4 MSN Laboratories Rosuvastatin Products Offered
11.3.5 MSN Laboratories Recent Development
11.4 Cadila Pharmaceuticals
11.4.1 Cadila Pharmaceuticals Corporation Information
11.4.2 Cadila Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Cadila Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Cadila Pharmaceuticals Rosuvastatin Products Offered
11.4.5 Cadila Pharmaceuticals Recent Development
11.5 LGM Pharma
11.5.1 LGM Pharma Corporation Information
11.5.2 LGM Pharma Description, Business Overview and Total Revenue
11.5.3 LGM Pharma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 LGM Pharma Rosuvastatin Products Offered
11.5.5 LGM Pharma Recent Development
11.6 Bal Pharma
11.6.1 Bal Pharma Corporation Information
11.6.2 Bal Pharma Description, Business Overview and Total Revenue
11.6.3 Bal Pharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bal Pharma Rosuvastatin Products Offered
11.6.5 Bal Pharma Recent Development
11.7 Changzhou Pharmaceutical Factory
11.7.1 Changzhou Pharmaceutical Factory Corporation Information
11.7.2 Changzhou Pharmaceutical Factory Description, Business Overview and Total Revenue
11.7.3 Changzhou Pharmaceutical Factory Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Changzhou Pharmaceutical Factory Rosuvastatin Products Offered
11.7.5 Changzhou Pharmaceutical Factory Recent Development
11.8 Jingxin Pharm
11.8.1 Jingxin Pharm Corporation Information
11.8.2 Jingxin Pharm Description, Business Overview and Total Revenue
11.8.3 Jingxin Pharm Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Jingxin Pharm Rosuvastatin Products Offered
11.8.5 Jingxin Pharm Recent Development
11.9 Zhejiang Hisun Pharmaceutical
11.9.1 Zhejiang Hisun Pharmaceutical Corporation Information
11.9.2 Zhejiang Hisun Pharmaceutical Description, Business Overview and Total Revenue
11.9.3 Zhejiang Hisun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Zhejiang Hisun Pharmaceutical Rosuvastatin Products Offered
11.9.5 Zhejiang Hisun Pharmaceutical Recent Development
11.10 HEC Pharm
11.10.1 HEC Pharm Corporation Information
11.10.2 HEC Pharm Description, Business Overview and Total Revenue
11.10.3 HEC Pharm Sales, Revenue and Gross Margin (2015-2020)
11.10.4 HEC Pharm Rosuvastatin Products Offered
11.10.5 HEC Pharm Recent Development
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description, Business Overview and Total Revenue
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Rosuvastatin Products Offered
11.1.5 AstraZeneca Recent Development
11.12 Nanjing Frochem Tech
11.12.1 Nanjing Frochem Tech Corporation Information
11.12.2 Nanjing Frochem Tech Description, Business Overview and Total Revenue
11.12.3 Nanjing Frochem Tech Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Nanjing Frochem Tech Products Offered
11.12.5 Nanjing Frochem Tech Recent Development
11.13 Lianyungang Runzhong Pharmaceutical
11.13.1 Lianyungang Runzhong Pharmaceutical Corporation Information
11.13.2 Lianyungang Runzhong Pharmaceutical Description, Business Overview and Total Revenue
11.13.3 Lianyungang Runzhong Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Lianyungang Runzhong Pharmaceutical Products Offered
11.13.5 Lianyungang Runzhong Pharmaceutical Recent Development
11.14 Shandong Bechem Chemicals
11.14.1 Shandong Bechem Chemicals Corporation Information
11.14.2 Shandong Bechem Chemicals Description, Business Overview and Total Revenue
11.14.3 Shandong Bechem Chemicals Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Shandong Bechem Chemicals Products Offered
11.14.5 Shandong Bechem Chemicals Recent Development
11.15 CTX Life Sciences
11.15.1 CTX Life Sciences Corporation Information
11.15.2 CTX Life Sciences Description, Business Overview and Total Revenue
11.15.3 CTX Life Sciences Sales, Revenue and Gross Margin (2015-2020)
11.15.4 CTX Life Sciences Products Offered
11.15.5 CTX Life Sciences Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Rosuvastatin Market Estimates and Projections by Region
12.1.1 Global Rosuvastatin Sales Forecast by Regions 2021-2026
12.1.2 Global Rosuvastatin Revenue Forecast by Regions 2021-2026
12.2 North America Rosuvastatin Market Size Forecast (2021-2026)
12.2.1 North America: Rosuvastatin Sales Forecast (2021-2026)
12.2.2 North America: Rosuvastatin Revenue Forecast (2021-2026)
12.2.3 North America: Rosuvastatin Market Size Forecast by Country (2021-2026)
12.3 Europe Rosuvastatin Market Size Forecast (2021-2026)
12.3.1 Europe: Rosuvastatin Sales Forecast (2021-2026)
12.3.2 Europe: Rosuvastatin Revenue Forecast (2021-2026)
12.3.3 Europe: Rosuvastatin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Rosuvastatin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Rosuvastatin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Rosuvastatin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Rosuvastatin Market Size Forecast by Region (2021-2026)
12.5 Latin America Rosuvastatin Market Size Forecast (2021-2026)
12.5.1 Latin America: Rosuvastatin Sales Forecast (2021-2026)
12.5.2 Latin America: Rosuvastatin Revenue Forecast (2021-2026)
12.5.3 Latin America: Rosuvastatin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Rosuvastatin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Rosuvastatin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Rosuvastatin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Rosuvastatin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Rosuvastatin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Rosuvastatin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Rosuvastatin Market Segments
Table 2. Ranking of Global Top Rosuvastatin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Rosuvastatin Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Purity 98.0%
Table 5. Major Manufacturers of Purity 99.0%
Table 6. Major Manufacturers of Other
Table 7. COVID-19 Impact Global Market: (Four Rosuvastatin Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Rosuvastatin Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Rosuvastatin Players to Combat Covid-19 Impact
Table 12. Global Rosuvastatin Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Rosuvastatin Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 14. Global Rosuvastatin Sales by Regions 2015-2020 (K MT)
Table 15. Global Rosuvastatin Sales Market Share by Regions (2015-2020)
Table 16. Global Rosuvastatin Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Rosuvastatin Sales by Manufacturers (2015-2020) (K MT)
Table 18. Global Rosuvastatin Sales Share by Manufacturers (2015-2020)
Table 19. Global Rosuvastatin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Rosuvastatin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rosuvastatin as of 2019)
Table 21. Rosuvastatin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Rosuvastatin Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Rosuvastatin Price (2015-2020) (USD/MT)
Table 24. Rosuvastatin Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Rosuvastatin Product Type
Table 26. Date of International Manufacturers Enter into Rosuvastatin Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Rosuvastatin Sales by Type (2015-2020) (K MT)
Table 29. Global Rosuvastatin Sales Share by Type (2015-2020)
Table 30. Global Rosuvastatin Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Rosuvastatin Revenue Share by Type (2015-2020)
Table 32. Rosuvastatin Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 33. Global Rosuvastatin Sales by Application (2015-2020) (K MT)
Table 34. Global Rosuvastatin Sales Share by Application (2015-2020)
Table 35. North America Rosuvastatin Sales by Country (2015-2020) (K MT)
Table 36. North America Rosuvastatin Sales Market Share by Country (2015-2020)
Table 37. North America Rosuvastatin Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Rosuvastatin Revenue Market Share by Country (2015-2020)
Table 39. North America Rosuvastatin Sales by Type (2015-2020) (K MT)
Table 40. North America Rosuvastatin Sales Market Share by Type (2015-2020)
Table 41. North America Rosuvastatin Sales by Application (2015-2020) (K MT)
Table 42. North America Rosuvastatin Sales Market Share by Application (2015-2020)
Table 43. Europe Rosuvastatin Sales by Country (2015-2020) (K MT)
Table 44. Europe Rosuvastatin Sales Market Share by Country (2015-2020)
Table 45. Europe Rosuvastatin Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Rosuvastatin Revenue Market Share by Country (2015-2020)
Table 47. Europe Rosuvastatin Sales by Type (2015-2020) (K MT)
Table 48. Europe Rosuvastatin Sales Market Share by Type (2015-2020)
Table 49. Europe Rosuvastatin Sales by Application (2015-2020) (K MT)
Table 50. Europe Rosuvastatin Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Rosuvastatin Sales by Region (2015-2020) (K MT)
Table 52. Asia Pacific Rosuvastatin Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Rosuvastatin Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Rosuvastatin Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Rosuvastatin Sales by Type (2015-2020) (K MT)
Table 56. Asia Pacific Rosuvastatin Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Rosuvastatin Sales by Application (2015-2020) (K MT)
Table 58. Asia Pacific Rosuvastatin Sales Market Share by Application (2015-2020)
Table 59. Latin America Rosuvastatin Sales by Country (2015-2020) (K MT)
Table 60. Latin America Rosuvastatin Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Rosuvastatin Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Rosuvastatin Revenue Market Share by Country (2015-2020)
Table 63. Latin America Rosuvastatin Sales by Type (2015-2020) (K MT)
Table 64. Latin America Rosuvastatin Sales Market Share by Type (2015-2020)
Table 65. Latin America Rosuvastatin Sales by Application (2015-2020) (K MT)
Table 66. Latin America Rosuvastatin Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Rosuvastatin Sales by Country (2015-2020) (K MT)
Table 68. Middle East and Africa Rosuvastatin Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Rosuvastatin Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Rosuvastatin Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Rosuvastatin Sales by Type (2015-2020) (K MT)
Table 72. Middle East and Africa Rosuvastatin Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Rosuvastatin Sales by Application (2015-2020) (K MT)
Table 74. Middle East and Africa Rosuvastatin Sales Market Share by Application (2015-2020)
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Major Businesses
Table 77. AstraZeneca Rosuvastatin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. AstraZeneca Product
Table 79. AstraZeneca Recent Development
Table 80. Teva Pharmaceutical Industries Corporation Information
Table 81. Teva Pharmaceutical Industries Description and Major Businesses
Table 82. Teva Pharmaceutical Industries Rosuvastatin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Teva Pharmaceutical Industries Product
Table 84. Teva Pharmaceutical Industries Recent Development
Table 85. MSN Laboratories Corporation Information
Table 86. MSN Laboratories Description and Major Businesses
Table 87. MSN Laboratories Rosuvastatin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. MSN Laboratories Product
Table 89. MSN Laboratories Recent Development
Table 90. Cadila Pharmaceuticals Corporation Information
Table 91. Cadila Pharmaceuticals Description and Major Businesses
Table 92. Cadila Pharmaceuticals Rosuvastatin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Cadila Pharmaceuticals Product
Table 94. Cadila Pharmaceuticals Recent Development
Table 95. LGM Pharma Corporation Information
Table 96. LGM Pharma Description and Major Businesses
Table 97. LGM Pharma Rosuvastatin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. LGM Pharma Product
Table 99. LGM Pharma Recent Development
Table 100. Bal Pharma Corporation Information
Table 101. Bal Pharma Description and Major Businesses
Table 102. Bal Pharma Rosuvastatin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Bal Pharma Product
Table 104. Bal Pharma Recent Development
Table 105. Changzhou Pharmaceutical Factory Corporation Information
Table 106. Changzhou Pharmaceutical Factory Description and Major Businesses
Table 107. Changzhou Pharmaceutical Factory Rosuvastatin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Changzhou Pharmaceutical Factory Product
Table 109. Changzhou Pharmaceutical Factory Recent Development
Table 110. Jingxin Pharm Corporation Information
Table 111. Jingxin Pharm Description and Major Businesses
Table 112. Jingxin Pharm Rosuvastatin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Jingxin Pharm Product
Table 114. Jingxin Pharm Recent Development
Table 115. Zhejiang Hisun Pharmaceutical Corporation Information
Table 116. Zhejiang Hisun Pharmaceutical Description and Major Businesses
Table 117. Zhejiang Hisun Pharmaceutical Rosuvastatin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Zhejiang Hisun Pharmaceutical Product
Table 119. Zhejiang Hisun Pharmaceutical Recent Development
Table 120. HEC Pharm Corporation Information
Table 121. HEC Pharm Description and Major Businesses
Table 122. HEC Pharm Rosuvastatin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. HEC Pharm Product
Table 124. HEC Pharm Recent Development
Table 125. Lunan Pharmaceutical Corporation Information
Table 126. Lunan Pharmaceutical Description and Major Businesses
Table 127. Lunan Pharmaceutical Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Lunan Pharmaceutical Product
Table 129. Lunan Pharmaceutical Recent Development
Table 130. Nanjing Frochem Tech Corporation Information
Table 131. Nanjing Frochem Tech Description and Major Businesses
Table 132. Nanjing Frochem Tech Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Nanjing Frochem Tech Product
Table 134. Nanjing Frochem Tech Recent Development
Table 135. Lianyungang Runzhong Pharmaceutical Corporation Information
Table 136. Lianyungang Runzhong Pharmaceutical Description and Major Businesses
Table 137. Lianyungang Runzhong Pharmaceutical Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Lianyungang Runzhong Pharmaceutical Product
Table 139. Lianyungang Runzhong Pharmaceutical Recent Development
Table 140. Shandong Bechem Chemicals Corporation Information
Table 141. Shandong Bechem Chemicals Description and Major Businesses
Table 142. Shandong Bechem Chemicals Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Shandong Bechem Chemicals Product
Table 144. Shandong Bechem Chemicals Recent Development
Table 145. CTX Life Sciences Corporation Information
Table 146. CTX Life Sciences Description and Major Businesses
Table 147. CTX Life Sciences Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. CTX Life Sciences Product
Table 149. CTX Life Sciences Recent Development
Table 150. Global Rosuvastatin Sales Forecast by Regions (2021-2026) (K MT)
Table 151. Global Rosuvastatin Sales Market Share Forecast by Regions (2021-2026)
Table 152. Global Rosuvastatin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 153. Global Rosuvastatin Revenue Market Share Forecast by Regions (2021-2026)
Table 154. North America: Rosuvastatin Sales Forecast by Country (2021-2026) (K MT)
Table 155. North America: Rosuvastatin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Europe: Rosuvastatin Sales Forecast by Country (2021-2026) (K MT)
Table 157. Europe: Rosuvastatin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Asia Pacific: Rosuvastatin Sales Forecast by Region (2021-2026) (K MT)
Table 159. Asia Pacific: Rosuvastatin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 160. Latin America: Rosuvastatin Sales Forecast by Country (2021-2026) (K MT)
Table 161. Latin America: Rosuvastatin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Middle East and Africa: Rosuvastatin Sales Forecast by Country (2021-2026) (K MT)
Table 163. Middle East and Africa: Rosuvastatin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 165. Key Challenges
Table 166. Market Risks
Table 167. Main Points Interviewed from Key Rosuvastatin Players
Table 168. Rosuvastatin Customers List
Table 169. Rosuvastatin Distributors List
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Rosuvastatin Product Picture
Figure 2. Global Rosuvastatin Sales Market Share by Type in 2020 & 2026
Figure 3. Purity 98.0% Product Picture
Figure 4. Purity 99.0% Product Picture
Figure 5. Other Product Picture
Figure 6. Global Rosuvastatin Sales Market Share by Application in 2020 & 2026
Figure 7. Tablet
Figure 8. Capsule
Figure 9. Others
Figure 10. Rosuvastatin Report Years Considered
Figure 11. Global Rosuvastatin Market Size 2015-2026 (US$ Million)
Figure 12. Global Rosuvastatin Sales 2015-2026 (K MT)
Figure 13. Global Rosuvastatin Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Rosuvastatin Sales Market Share by Region (2015-2020)
Figure 15. Global Rosuvastatin Sales Market Share by Region in 2019
Figure 16. Global Rosuvastatin Revenue Market Share by Region (2015-2020)
Figure 17. Global Rosuvastatin Revenue Market Share by Region in 2019
Figure 18. Global Rosuvastatin Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Rosuvastatin Revenue in 2019
Figure 20. Rosuvastatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Rosuvastatin Sales Market Share by Type (2015-2020)
Figure 22. Global Rosuvastatin Sales Market Share by Type in 2019
Figure 23. Global Rosuvastatin Revenue Market Share by Type (2015-2020)
Figure 24. Global Rosuvastatin Revenue Market Share by Type in 2019
Figure 25. Global Rosuvastatin Market Share by Price Range (2015-2020)
Figure 26. Global Rosuvastatin Sales Market Share by Application (2015-2020)
Figure 27. Global Rosuvastatin Sales Market Share by Application in 2019
Figure 28. Global Rosuvastatin Revenue Market Share by Application (2015-2020)
Figure 29. Global Rosuvastatin Revenue Market Share by Application in 2019
Figure 30. North America Rosuvastatin Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Rosuvastatin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Rosuvastatin Sales Market Share by Country in 2019
Figure 33. North America Rosuvastatin Revenue Market Share by Country in 2019
Figure 34. U.S. Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Rosuvastatin Market Share by Type in 2019
Figure 39. North America Rosuvastatin Market Share by Application in 2019
Figure 40. Europe Rosuvastatin Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Rosuvastatin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Rosuvastatin Sales Market Share by Country in 2019
Figure 43. Europe Rosuvastatin Revenue Market Share by Country in 2019
Figure 44. Germany Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Rosuvastatin Market Share by Type in 2019
Figure 55. Europe Rosuvastatin Market Share by Application in 2019
Figure 56. Asia Pacific Rosuvastatin Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Rosuvastatin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Rosuvastatin Sales Market Share by Region in 2019
Figure 59. Asia Pacific Rosuvastatin Revenue Market Share by Region in 2019
Figure 60. China Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Rosuvastatin Market Share by Type in 2019
Figure 83. Asia Pacific Rosuvastatin Market Share by Application in 2019
Figure 84. Latin America Rosuvastatin Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Rosuvastatin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Rosuvastatin Sales Market Share by Country in 2019
Figure 87. Latin America Rosuvastatin Revenue Market Share by Country in 2019
Figure 88. Mexico Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Rosuvastatin Market Share by Type in 2019
Figure 95. Latin America Rosuvastatin Market Share by Application in 2019
Figure 96. Middle East and Africa Rosuvastatin Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Rosuvastatin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Rosuvastatin Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Rosuvastatin Revenue Market Share by Country in 2019
Figure 100. Turkey Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Rosuvastatin Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Rosuvastatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure
  • COVID-19 Outbreak-Global Atorvastatin Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 07-Jul-2020        Price: US 3660 Onwards        Pages: 114
    The Atorvastatin market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, indust......
  • COVID-19 Outbreak-Global Simvastatin Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 07-Jul-2020        Price: US 3660 Onwards        Pages: 104
    The Simvastatin market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industr......
  • Global Pitavastatin Market Research Report 2020 (Covid-19 Version)
    Published: 05-Jul-2020        Price: US 3500 Onwards        Pages: 133
    Summary Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - 1 mg - 2 mg - Others By Application - Hospital use - Clinic - Others By Company - Kowa Company - Shandong Qidu Pharmaceutical - Wanbang Biopharmaceuticals - CSPC Pharma - Zhejiang Jingxin......
  • COVID-19 Impact on Global Cilostazol, Market Insights and Forecast to 2026
    Published: 30-Jun-2020        Price: US 3900 Onwards        Pages: 154
    Cilostazol market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cilostazol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Cilostazol market is segmented into - Injection - Freeze-dried Powder - Oral Segment by Appl......
  • COVID-19 Impact on Global Rosuvastatin, Market Insights and Forecast to 2026
    Published: 29-Jun-2020        Price: US 3900 Onwards        Pages: 154
    Rosuvastatin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rosuvastatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Rosuvastatin market is segmented into - Purity 98.0% - Purity 99.0% - Other Segment by A......
  • COVID-19 Outbreak-Global Heart Failure Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 28-Jun-2020        Price: US 3660 Onwards        Pages: 105
    The Heart Failure Drugs market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industr......
  • COVID-19 Outbreak-Global Congestive Heart Failure Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 28-Jun-2020        Price: US 3660 Onwards        Pages: 103
    Congestive heart failure is a serious and complex condition in which the heart muscles are either damaged or have to work too hard. Although the heart beats, the damaged heart muscles are too weak to pump sufficient oxygen-rich blood to and from the body. ACE inhibitors/ARB antagonists, beta-adrenergic receptor blocking agents, diuretics, and inotropic drugs are the medications available for the treatment of congestive heart failure.The Congestive Heart Failure Drugs market revenue was xx.xx Mil......
  • Global Congestive Heart Failure Drugs Market Research Report 2020 (Covid-19 Version)
    Published: 27-Jun-2020        Price: US 3500 Onwards        Pages: 177
    Summary Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - Injection - Capsule - Tablets By Application - Hospital Pharmacies - Retail Pharmacies - Online Pharmacies By Company - Sanofi - Novartis - Pfizer - Merck & Co - AstraZeneca - GSK......
  • COVID-19 Outbreak-Global Atherosclerosis Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 23-Jun-2020        Price: US 3660 Onwards        Pages: 114
    The Atherosclerosis Drugs market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, indus......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs